CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE25770.05-29.1 (-0.11 %)
PREV CLOSE () 25799.15
OPEN PRICE () 25900.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 697
TODAY'S LOW / HIGH ()25700.00 25963.90
52 WK LOW / HIGH ()25350 35921.55
NSE25780.000 (0 %)
PREV CLOSE() 25780.00
OPEN PRICE () 25965.00
BID PRICE (QTY) 25780.00 (3)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9771
TODAY'S LOW / HIGH() 25620.00 25970.00
52 WK LOW / HIGH ()25350 37000
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1944

Management Info :

Munir Shaikh - Chairman Kartik Rajendran - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022-50461000 / 2000 / 67978888

Website : www.abbott.co.in

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
08Apr Abbott India informs about certificate
In terms of Regulation 74(5) of the Securities and Exchange Board of Ind..
02Mar Abbott India inches up on inking pact
Abbott India is currently trading at Rs. 26598.50, up by 103.35 points o..
27Feb Abbott India inks pact with Novo Nordi
Abbott India has entered into strategic collaboration with Novo Nordisk..
13Feb Abbott India informs about press release
Abbott India has informed that it enclosed Newspaper Publication of the..
04Feb Abbott India informs about board meet
In terms of Regulation 29(1)(a) of the Securities and Exchange Board of..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit3759.614144.4
Gross Profit 5089.8 18869.5
Operating Profit 5332.319701.8
Net Sales 17240.464091.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 8291.50 (2.93%)
M.Cap ( in Cr)
20728.75
Neuland Laboratories (BSE)
 14948.95 (1.46%)
M.Cap ( in Cr)
19179.34
Divi's Lab (BSE)
 6119.50 (2.72%)
M.Cap ( in Cr)
162453.50
Procter&Gamble Healt (BSE)
 4943.65 (2.88%)
M.Cap ( in Cr)
8206.15
Pfizer (BSE)
 4865.30 (2.46%)
M.Cap ( in Cr)
22257.64
Shareholding Pattern
PROMOTERS 74.99%
NON-INSTITUTION 15.81%
MUTUAL FUNDS/UTI 7.68%
FI/BANKS/INSURANCE 1.06%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77550.25918.60 (1.20%)
NIFTY24050.60275.50 (1.16%)
Dow Jones 47916.57-269.23 (-0.56%)
Nasdaq 22902.8980.47 (0.35%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI